Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 48 citing articles:

Targeting pyroptosis in breast cancer: biological functions and therapeutic potentials on It
Cong Chen, Qianwei Ye, Linbo Wang, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 18
Gasdermins: a dual role in pyroptosis and tumor immunity
Jiayi Yang, Jingting Jiang
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Nottingham Prognostic Index relation to cytokine-producing tumor molecular subtypes in breast cancer
А. А. Студеникина, А. В. Проскура, А. I. Autenshlyus
Russian Journal of Preventive Medicine (2025) Vol. 28, Iss. 1, pp. 63-63
Closed Access
miR-1290 modulates the radioresistance of triple-negative breast cancer by targeting NLRP3-mediated pyroptosis
Yingjia Li, Xiang Li
Clinical & Translational Oncology (2022) Vol. 24, Iss. 9, pp. 1764-1775
Closed Access | Times Cited: 20
A Prognostic Signature Consisting of Pyroptosis-Related Genes and SCAF11 for Predicting Immune Response in Breast Cancer
Ling Chu, Qiaoli Yi, Yuanliang Yan, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 20
Revolutionizing breast cancer treatment: Harnessing the related mechanisms and drugs for regulated cell death (Review)
Leyu Ai, Na Yi, Chunhan Qiu, et al.
International Journal of Oncology (2024) Vol. 64, Iss. 5
Open Access | Times Cited: 3
Polydatin down-regulates the phosphorylation level of STAT3 and induces pyroptosis in triple-negative breast cancer mice with a high-fat diet
Min Liu, Yinan Li, Bingtan Kong, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 4, pp. 173-173
Open Access | Times Cited: 17
Biallelic NLRP7 variants in patients with recurrent hydatidiform mole: A review and expert consensus
Rima Slim, Rosemary A. Fisher, Florian Milhavet, et al.
Human Mutation (2022) Vol. 43, Iss. 12, pp. 1732-1744
Open Access | Times Cited: 17
The Pyroptosis-Related Gene Signature Predicts the Prognosis of Hepatocellular Carcinoma
Shuqiao Zhang, Xinyu Li, Xiang Zhang, et al.
Frontiers in Molecular Biosciences (2022) Vol. 8
Open Access | Times Cited: 16
Identification of a Pyroptosis-Related Gene Signature and Effect of Silencing the CHMP4C and CASP4 in Pancreatic Adenocarcinoma
Yajun Chen, Yiming Liu, Menghao Wang
International Journal of General Medicine (2022) Vol. Volume 15, pp. 3199-3213
Open Access | Times Cited: 14
A novel pyroptosis-related prognostic lncRNAs signature, tumor immune microenvironment and the associated regulation axes in bladder cancer
Xiaocong Mo, Di Hu, Yin Li, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 14
Emerging roles of ferroptosis in glioma
Jiaqi Shi, Ning Yang, Mingzhi Han, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 14
Constructing and validating of m6a-related genes prognostic signature for stomach adenocarcinoma and immune infiltration: Potential biomarkers for predicting the overall survival
Jing Yang, Zixuan Wu, Xiaoxi Wu, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 14
Stat5 inhibits NLRP3‐mediated pyroptosis to enhance chemoresistance of breast cancer cells via promoting miR‐182 transcription
Peng Wan, Xiaolan He, Ying Han, et al.
Chemical Biology & Drug Design (2023) Vol. 102, Iss. 1, pp. 14-25
Closed Access | Times Cited: 8
The role of pyroptosis and its crosstalk with immune therapy in breast cancer
Ling Wu, Hongsheng Lu, Yin Pan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Identification and validation of a pyroptosis-related prognostic model for colorectal cancer
Ruibin Li, Shiyao Zhang, Gang Liu
Functional & Integrative Genomics (2022) Vol. 23, Iss. 1
Closed Access | Times Cited: 13
A Novel Pyroptotic and Inflammatory Gene Signature Predicts the Prognosis of Cutaneous Melanoma and the Effect of Anticancer Therapies
Yujian Xu, Youbai Chen, Zehao Niu, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 12
Role of gasdermin family proteins in cancers (Review)
Xin Yang, Zhe Tang
International Journal of Oncology (2023) Vol. 63, Iss. 3
Open Access | Times Cited: 7
A novel risk score model based on pyroptosis-related genes for predicting survival and immunogenic landscape in hepatocellular carcinoma
Hongyu Wang, Bo Zhang, Yanan Shang, et al.
Aging (2023)
Open Access | Times Cited: 6
Glutamine metabolism genes prognostic signature for stomach adenocarcinoma and immune infiltration: potential biomarkers for predicting overall survival
Hui Li, Zixuan Wu, Yu Zhang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
A novel Pyroptosis‐related long non‐coding RNA signature for predicting the prognosis and immune landscape of head and neck squamous cell carcinoma
Chongchang Zhou, Yiming Shen, Yangli Jin, et al.
Cancer Medicine (2022) Vol. 11, Iss. 24, pp. 5097-5112
Open Access | Times Cited: 9
Development of a prognostic prediction model based on a combined multi-omics analysis of head and neck squamous cell carcinoma cell pyroptosis-related genes
Bin Chen, Yuanbo Luo, Xueran Kang, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 9
Clinical signature and associated immune metabolism of NLRP1 in pan‐cancer
Yong Liao, Pinglian Yang, Cui Yang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 18
Open Access | Times Cited: 1
Immune landscape and risk prediction based on pyroptosis-related molecular subtypes in triple-negative breast cancer
Lixi Luo, Qun Wei, Chenpu Xu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Establishment of a N1-methyladenosine-related risk signature for breast carcinoma by bioinformatics analysis and experimental validation
Leilei Li, Wenhui Yang, Daqi Jia, et al.
Breast Cancer (2023) Vol. 30, Iss. 4, pp. 666-684
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top